James Mullen compensation by year
Editas Medicine Summary Compensation Table · the one fiscal year held| Component | FY2021 |
|---|---|
| Salary | $540,865 |
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $5,780,000 |
| Non-equity incentive | $361,644 |
| Pension and deferred compensation | $0 |
| All other | $32,002 |
| Total | $6,714,511 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 18, 2023, accession 0001104659-23-046732, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Editas Medicine, Inc. filed document, accession 0001104659-23-046732. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2023.
Editas Medicine’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| James Mullen · this page | Executive Chair; Former President and Chief Executive Officer | $6,714,511 |
| Michelle Robertson | Former Executive Vice President and Chief Financial Officer | $2,247,017 |
| Bruce Eaton | Former Executive Vice President and Chief Business Officer | $1,840,813 |
Board service
Editas Medicine board · FY2023| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2023 | $0 | — | $0 | $168,152 | $168,152 |
Each year as the company reported it in Editas Medicine's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: Editas Medicine pays directors a $40,000 cash retainer and $300,000 in Options. As stated in Editas Medicine's FY2023 proxy.
The full Editas Medicine compensation record
free company briefThis page is one person within Editas Medicine's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Editas Medicine proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Editas Medicine's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.